Author

ANNE E. FARMER

King's College London

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 3 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:GWAS summary statistics· 4 Organism:human· 4 Approach:statistical model· 4 Research Focus:GWAS / association mapping· 3 Approach:matrix factorization· 1 Research Focus:polygenic risk· 1

Frequent Co-Authors

Joanna HauseriD· 4 shared Anna Placentino· 3 shared Cathryn M. LewisiD· 3 shared Charles J. C. CurtisiD· 3 shared Chiara FabbriiD· 3 shared Daniel SoueryiD· 3 shared Gerome D. BreeniD· 3 shared Glyn LewisiD· 3 shared

Activity by Year

2017-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersGenetics

Joanna HauserORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Shared Genetic Risk between Eating Disorder- and Substance-Use-Related Phenotypes: Evidence from Genome-Wide Association Studies

Melissa A. Munn‐Chernoff, Emma C. Johnson, Yi‐Ling Chou, Jonathan R. I. Coleman, Laura M. Thornton, Raymond Kenney Walters, Zeynep Yılmaz, Jessica H. Baker, Christopher Hübel, Scott D. Gordon, Sarah Elizabeth Medland, Hunna J. Watson, Héléna A. Gaspar, Julien Bryois, Anke Hinney, , Maria C. La Via

The paper estimates genetic correlations between eating disorder and substance-use-related phenotypes using GWAS data, finding both positive and negative associations.

Addiction Biology · Feb 16, 2020Peer-reviewedGenetics

Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: meta-analysis of data from genome-wide association studies

Chiara Fabbri, Katherine E. Tansey, Roy H. Perlis, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole N Mors, Anna Placentino, Marcella Rietschel, Daniel Souery, Gerome D. Breen, Charles J. C. Curtis, Sang‐Hyuk Lee, Stephen Newhouse, Hamel Patel, , Cathryn M. Lewis

This paper conducts a meta-analysis showing that CYP2C19 poor metabolizers have better antidepressant efficacy but similar side effects compared to extensive metabolizers.

European Neuropsychopharmacology · Jun 28, 2018Peer-reviewedGenetics

New insights on the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation

Chiara Fabbri, Katherine E. Tansey, Roy H. Perlis, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole N Mors, Anna Placentino, Marcella Rietschel, Daniel Souery, Gerome D. Breen, Charles J. C. Curtis, L Sang-Hyuk, Stephen Newhouse, Hamel Patel, , Cathryn M. Lewis

This study identifies two SNPs associated with antidepressant response in GENDEP and STAR*D studies but finds limited replication in independent cohorts.

The Pharmacogenomics Journal · Nov 21, 2017Peer-reviewedGenomics

Pharmacogenetics of antidepressant response: a polygenic approach

Judit García‐González, Katherine E. Tansey, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole N Mors, Anna Placentino, Marcella Rietschel, Daniel Souery, Tina Žagar, Piotr M. Czerski, Borut Jerman, Henriette N. Buttenschøn, Thomas G. Schulze, Astrid W. Zobel, , Chiara Fabbri

This study investigates whether polygenic risk scores (PRS) can predict antidepressant response in MDD, finding no significant predictive effect.

Progress in Neuro-Psychopharmacology and Biological Psychiatry · Jan 31, 2017Peer-reviewedGenetics